Utility of a Mobile Application for Young Women With Breast Cancer

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · May 28, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to see how a mobile application can help young women with breast cancer communicate better and manage feelings of distress related to their illness. The study is specifically focused on women aged 18 to 45, who are patients at a specific cancer center and have been diagnosed with any type of breast cancer. To participate, women need to have a certain level of distress related to their cancer, have access to a mobile device and an email address, and be able to read and understand English.

If eligible, participants will use the mobile app as part of the study to help track their feelings and experiences during treatment. This could provide valuable insights into how technology can support young women facing the challenges of breast cancer. It’s important to note that the trial is not yet recruiting participants, so there is still time for potential candidates to learn more about the study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Ability to understand and willingness to sign an IRB-approved informed consent
• • Age ≥ 18 and ≤ 45 years at the time of consent
• • Female
• • Established patient at Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC)
• • Histological confirmation of any type and stage (0-IV) of breast cancer
• • Screening (baseline) NCCN Distress Thermometer score ≥ 4
• • Access to a mobile device for trial purposes and an active email address
• • Ability to read and understand the English language. NOTE: The Mighty Pro Application is available in English only.
• • As determined by the enrolling Investigator, ability of the participant to understand and comply with study procedures for the entire length of the study
• Exclusion Criteria:
• • - None